Skip to main content
. 2020 Jul 7;9(1):1497–1505. doi: 10.1080/22221751.2020.1780951

Figure 3.

Figure 3.

Analysis of antibody binding from COVID-19 and SARS sera against seven recombinant proteins. Show on the Y-axis are net mean florescence (MFI) units normalised with those obtained from anti-His antibody readings for each protein (see Methods for detail). The serum panels includes 37 healthy controls, 74 sera from PCR positive COVID-19 patients, and 18 recovered SARS patients. The SARS sera were divided into those sampled in 2003 (<1 year, n=7) or 2020 (≥17 years n=11).